/XBIOW

XBIOW Stock - Xenetic Biosciences, Inc.

Q: What is the analyst price target for XBIOW?

Analyst price target information is not currently available for XBIOW.

Q: What is XBIOW's market cap?

Market capitalization information is not currently available for XBIOW.

Healthcare|Biotechnology|NASDAQ

$17.54-23.54%

$5.40 (-23.54%) • Jul 16

GoAI Score

Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.

HOLD

Medium Confidence

Momentum

Momentum Score

Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.

100

Sentiment

Sentiment Score

Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).

Risk Score

Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.

Price Target

Average analyst price target from the last quarter. Shows expected upside/downside from current price.

+10.0%upside

Target: $19.29

AI Analysis PreviewPremium

Real-time AI-powered market analysis

Precise entry/exit price targets

Risk assessment & position sizing

Unlock GoAI Insights for XBIOW

Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.

Buy/Sell Signals

94% win rate on Alpha signals

Deep Analysis

Institutional-grade thesis

Real-Time Alerts

SMS & push notifications

Risk Scoring

Multi-factor analysis

Free 14-day trial • No credit card required

Financial Statements

Revenue & Profitability Trend

FY2020

FY2021

FY2022

FY2023

FY2024

← Swipe to see more →

Revenue

Net Income (Profit)

Net Loss

Key Metrics

Market CapN/A

P/E RatioN/A

Beta2.30

52W High$20.50

52W Low$1.02

Avg VolumeN/A

Income Statement (Fiscal Year)

Metric	FY2024	FY2023	FY2022	FY2021	FY2020
Revenue	$2.50M	$2.54M	$1.71M	$1.16M	$436,942
Gross Profit	$2.50M	$2.54M	$1.71M	$1.16M	$436,942
Gross Margin	100.0%	100.0%	100.0%	100.0%	100.0%
Operating Income	$-4,204,428	$-4,515,715	$-6,717,908	$-5,746,765	$-13,937,663
Net Income	$-3,960,275	$-4,134,578	$-6,552,353	$-5,645,179	$-10,893,466
Net Margin	-158.4%	-162.8%	-383.9%	-486.4%	-2493.1%
EPS	$-2.57	$-2.71	$-4.49	$-5.39	$-17.04

Company Overview

Xenetic Biosciences, Inc., a biopharmaceutical company, focuses on advancing XCART, a personalized chimeric antigen receptor T cell (CAR T) platform technology engineered to target patient-specific tumor neoantigens. The company engages in the development of biologic drugs and therapeutics. It advances cell-based therapeutics targeting the B-cell receptor on the surface of an individual patient's malignant tumor cells for the treatment of B-cell lymphomas. In addition, the company leveraging PolyXen, its proprietary drug delivery platform, by partnering with biotechnology and pharmaceutical companies. It has collaboration agreements with Takeda Pharmaceutical Co. Ltd., Serum Institute of India Limited, and PJSC Pharmsynthez. Xenetic Biosciences, Inc. is headquartered in Framingham, Massachusetts.

Visit Website

Earnings History & Surprises

XBIOW

Beat Rate

Last 0 quarters

Avg Surprise

+0%

EPS vs Estimate

Beats / Misses

0/0

Last 12 quarters

Latest EPS

$-0.69

Q3 2023

EPS Surprise History

Q4 22

No data

Q1 23

No data

Q2 23

No data

Q3 23

No data

Beat Estimate

Missed Estimate

Quarterly EPS Details

Period	Report Date	Estimated EPS	Actual EPS	Surprise	Result
Q3 2023	Sep 30, 2023	—	$-0.69	—	—
Q2 2023	Jun 30, 2023	—	$-0.69	—	—
Q1 2023	Mar 31, 2023	—	$-0.05	—	—
Q4 2022	Dec 31, 2022	—	$-0.10	—	—

Frequently Asked Questions about XBIOW

What is XBIOW's current stock price?

Xenetic Biosciences, Inc. (XBIOW) is currently trading at $17.54 per share. The stock has moved -23.54% today.

What is the analyst price target for XBIOW?

No analyst price targets are currently available for this stock.

What sector is Xenetic Biosciences, Inc. in?

Xenetic Biosciences, Inc. operates in the Healthcare sector, specifically within the Biotechnology industry. The company is traded on the NASDAQ exchange.

What is XBIOW's market cap?

Xenetic Biosciences, Inc. has a market capitalization of $0.01 billion, making it a small-cap company.

Does XBIOW pay dividends?

No, Xenetic Biosciences, Inc. does not currently pay a dividend to shareholders.